Get Personal

With its purchase of SeqWright for an undisclosed sum, GE is investing more in personalized medicine, The Wall Street Journal's Health Blog says. SeqWright is a contract genomic research organization that offers sequencing services among others, and GE says the company will supplement its 2009 purchase of Clarient, a cancer diagnostics company, for $580 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Technology Review reports that researchers in the US have used CRISPR to modify a number of human embryos.

By introducing genes from butterfly peas and Canterbury bells, researchers in Japan have developed a blue chrysanthemum, according to NPR.

Plant researchers plan to sequence some 10,000 samples that represent the major plant clades, ScienceInsider reports.

In Nature this week: a Danish reference genome, and more.